Table 1.
HC | MCI | AD | p - value | |
---|---|---|---|---|
N | 31 | 6 | 7 | |
Age (years) | 71.8 (5.6) | 68.3 (4.5) | 71.3 (7.1) | 0.40 |
Sex (F%) | 58 % | 50 % | 28 % | 0.41 |
APOEε4 % | 19 % | 0 % | 43 % | 0.20 |
MMSE (median IQR) | 29 (1.5) | 26 (2) | 22 (3) | <0.0001 |
CDR (median IQR) | 0 (0) | 0.5 (0) | 1 (0.25) | <0.0001 |
p–value determined by t-test (age), Chi square analyses (APOEε4 and sex) and Kruskal-Wallis tests (CDR score and MMSE)
N number, HC health control, MCI mild cognitive impairment, AD Alzheimer’s disease, APOEε4 apolipoprotein epsilon 4 allele, MMSE Mini–Mental State Examination, CDR Clinical Dementia Rating, IQR inter-quartile range